Dr. Anne Greist, MD

Dr. Greist practices at IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health.

Dr. Greist's NPI, 1063477073, was assigned on April 20, 2006. Dr. Greist holds Indiana license 01033362A.

Dr. Greist's primary practice is IU Health Methodist Hospital, at 1701 N Senate Blvd, Indianapolis, IN 46202 in Marion County. The practice phone is (317) 962-2000.

Dr. Greist's primary practice is IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health. The medical group on file is IU Health Medical Group. Dmand AI also links Dr. Greist to 4 more group practices and clinics, 3 medical groups and 1 behavioral health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Greist practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Greist's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Greist is licensed in Indiana.

CMS data shows 40 Medicare services from Dr. Greist across 1 procedure code in 2024, all of them office visits, for 45 Medicare patients. Medicare paid $1,893 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 45 Medicare patients who saw Dr. Greist in 2024. The largest group is under 65, with 20 patients. 64% of them have high blood pressure, and 62% have high cholesterol. 51% are also on Medicaid. Their average risk score is 5.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Greist's median patient age at 56, with 65% women.

In 2024, Dr. Greist wrote 614 Medicare Part D claims for 103 patients. 54% of them were for generic drugs. CMS names the drug for 503 of them, across 15 drugs with 11 or more claims each, at $428,885 in total drug cost. In 2023, CMS named 1,407 claims across 34 drugs.

Dr. Greist accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Greist, published from 2015 to 2024. 2015 was the busiest year, with 2. The most frequent topics are Hemophilia A, Anemia, Sickle Cell and Autoantibodies. Dr. Greist has published most often in Haemophilia. Dr. Greist's most frequent co-authors are Amy Dana Shapiro, MD, Nihal Bakeer, MD and Rebecca Kruse-Jarres, MD.

Dmand AI links Dr. Greist to 3 clinical trials, 2 of them phase 4 studies. 1 is still active or recruiting. Conditions studied include Anemia, Sickle Cell, Hemophilia A and Anemia, Hemolytic, Congenital. Indiana Hemophilia &Thrombosis Center, Inc. sponsors the most, 2.

CMS Open Payments shows 5 general payments to Dr. Greist from 5 drug and device companies from 2016 to 2021. Food and beverage make up the largest share, 100% of the total. Agios Pharmaceuticals, Inc. paid the most, $140. It also lists 2 research payments totaling $9,486 in 2020.